Company / Accounts Receivable
AETHLON MEDICAL INC Accounts Receivable History
FY2014-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
-
FY2023
5-year range
$0 / $206.7K
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $149,082 to $0 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- AETHLON MEDICAL INC's accounts receivable has declined for 3 consecutive years.
- In FY2023, accounts receivable decreased 100.0% year-over-year.
- Peak accounts receivable was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $128.0K | -14.2% |
| FY2021 | $149.1K | -27.9% |
| FY2020 | $206.7K | +176.3% |
| FY2018 | $74.8K | - |
| FY2017 | $0 | -100.0% |
| FY2016 | $199.5K | +3.2% |
| FY2015 | $193.3K | +103.1% |
| FY2014 | $95.2K | -54.4% |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026